NEW YORK, Dec 13 - Incyte Genomics said Wednesday it has formed two genomic research partnerships with leading academic institutions to study common diseases.

The company is partnering with the University of California San Francisco to study prostate cancer, and with CARIM, the Maastricht Cardiovascular Research Institute in the Netherlands to study cardiovascular disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.